Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-04

Clinical Trial Update: Dysport in Post-Surgical Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial update for Dysport in post-surgical neuralgia showing completed study with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Chronic Scar Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-12-04